Vortioxetine

Vortioxetine Reactions 1680, p338 - 2 Dec 2017 Hyponatraemia complicated by flutter and thromboembolic stroke: case report A 72-year-old woman developed hyponatraemia complicated by flutter and thromboembolic stroke, and died during treatment with vortioxetine [route not stated]. The woman was evaluated for low mood, loss of interest, anhedonia, tiredness, little concentration and decreased activity in March 2016. Since the age of 55 years, she had a history of recurrent depressive disorder with multiple prior hospitalisations. The hospitalisations were due to severe hyponatraemia associated with different psychotropic drugs. Currently, she was on a treatment with maprotiline. Vortioxetine 5mg was added to the therapy, which was then maintained at 10 mg/day after four weeks. Twenty six days later, she was admitted to the ICU from the emergency department, after presenting with a seizure. After 13 days of the admission, despite recovering sodium levels, she presented with a decreased level of consciousness. She was given a diagnosis of thromboembolic stroke as a complication of a flutter. She had developed flutter during the initial days of the therapy. The woman died few minutes after presenting with asystole and agonic respiration, despite resuscitation attempts. Author comment: As for the risk, we have observed a fatal case of hyponatremia associated with the use of vortioxetine in our hospital. [P]roposing as diagnosis a thromboembolic stroke as a complication of a flutter suffered during the first days. Pelayo-Teran JM, et al. Safety in the use of antidepressants: Vortioxetine-induce hyponatremia in a case report. Revista de Psiquiatria y Salud Mental 10: 219-220, No. 4, Oct-Dec 2017. Available from: URL: http://doi.org/10.1016/ j.rpsm.2017.07.001 [Spanish; summarised from a translation] - Spain 803285474 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Vortioxetine

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page
Loading next page...
1 Page
 
/lp/springer_journal/vortioxetine-1OLOP21AJY
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-39269-1
Publisher site
See Article on Publisher Site

Abstract

Reactions 1680, p338 - 2 Dec 2017 Hyponatraemia complicated by flutter and thromboembolic stroke: case report A 72-year-old woman developed hyponatraemia complicated by flutter and thromboembolic stroke, and died during treatment with vortioxetine [route not stated]. The woman was evaluated for low mood, loss of interest, anhedonia, tiredness, little concentration and decreased activity in March 2016. Since the age of 55 years, she had a history of recurrent depressive disorder with multiple prior hospitalisations. The hospitalisations were due to severe hyponatraemia associated with different psychotropic drugs. Currently, she was on a treatment with maprotiline. Vortioxetine 5mg was added to the therapy, which was then maintained at 10 mg/day after four weeks. Twenty six days later, she was admitted to the ICU from the emergency department, after presenting with a seizure. After 13 days of the admission, despite recovering sodium levels, she presented with a decreased level of consciousness. She was given a diagnosis of thromboembolic stroke as a complication of a flutter. She had developed flutter during the initial days of the therapy. The woman died few minutes after presenting with asystole and agonic respiration, despite resuscitation attempts. Author comment: As for the risk, we have observed a fatal case of hyponatremia associated with the use of vortioxetine in our hospital. [P]roposing as diagnosis a thromboembolic stroke as a complication of a flutter suffered during the first days. Pelayo-Teran JM, et al. Safety in the use of antidepressants: Vortioxetine-induce hyponatremia in a case report. Revista de Psiquiatria y Salud Mental 10: 219-220, No. 4, Oct-Dec 2017. Available from: URL: http://doi.org/10.1016/ j.rpsm.2017.07.001 [Spanish; summarised from a translation] - Spain 803285474 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680

Journal

Reactions WeeklySpringer Journals

Published: Dec 2, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off